Trial Profile
Phase 1 Study of Anti-Glycation Agent GLY-230
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs GLY 230 (Primary)
- Indications Diabetic complications
- Focus Pharmacokinetics
- Sponsors Glycadia
- 15 Nov 2007 New trial record.